✓ Medically reviewed by Dr. Anjmun Sharma, MD · Updated 2026-06-26

Weight-Loss Evidence and Science: A Reader's Guide

Dr. Anjmun Sharma's honest guide to reading the science of weight and metabolic health, from what the major trials show to how to judge a study yourself.

Weight loss evidence and science is the body of careful research that tells us what actually helps people lose weight and keep it off, and how much we can trust each finding. Good evidence is repeated, reviewed by independent experts, honest about its limits, and consistent across many studies rather than resting on one bold headline. This hub teaches you to read that science yourself.

I am Dr. Anjmun Sharma, and I built this pillar because most of what reaches patients is not the science. It is the science after marketing, social media, and a hurried news cycle have each taken a turn. A single trial becomes a promise. An average becomes a guarantee. A caution written by careful authors gets quietly dropped. My job, both as a physician and as a fair reviewer, is to hand the caution back to you.

Why does reading the evidence matter for your own care?

Because the difference between a claim you can build a treatment plan on and one you should file under "interesting, watch this" is not obvious from the outside. Both can sound confident. Both can cite a study. What separates them is whether the result has been tested more than once, checked by people who did not run the study, stated with honest limits, and paired with disclosed funding and conflicts. When you can spot those qualities, you stop being at the mercy of whoever markets the loudest, and you start asking the questions a good clinician asks.

The major trials in this field are genuinely encouraging, and I will not undersell them. Large, careful studies of GLP-1 medicines have shown meaningful weight loss and, in some populations, cardiometabolic benefits that go beyond the scale. That is real. But those same trials report their results as averages, with a wide range of individual outcomes underneath. Some people did far better than the headline. Some did much less. A study that is true on average can still not apply to you, which is why I titrate slowly, watch how your body actually responds, and tell you plainly what I know firmly and what I know loosely.

What does honest evidence sound like from your clinician?

It sounds like someone who can say "the evidence is strong here" and "we are less sure here" in the same visit without losing your trust. Honest uncertainty is not indecision. It is naming what we know firmly, what we know loosely, and what we do not yet know, and then still making a reasonable plan with you. A clinician who is certain about everything has usually stopped reading.

Ready to start?

$199 Skeptics' Trial, see if it works for you

One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.

Start the 30-day trial

There is one finding I want you to carry into everything else on this site, because it reframes the whole conversation. After weight loss, your biology pushes back. Hunger rises and hormones shift in ways that favor regaining the weight. That is not a character flaw or a failure of willpower. It is physiology, and it is well documented across years of research on people who lost weight and worked to keep it off. Understanding that changes how you read every product promise. Weight maintenance is its own distinct phase of care, not an afterthought, and any plan that treats it as automatic has skipped the hard part.

How does this hub help you become a sharper reader?

The guides below take the pieces one at a time. Some walk you through how to read a single study without being fooled by its headline. Some review what the major trials actually show, in plain language, with the cautions left in. Some explain the standard of care and the clinical guidelines that reasonable physicians follow, so you can tell a considered plan from an improvised one. None of them ask you to take my word for it. That is the point. The goal is not for you to trust me because I sound confident. It is for you to trust the reasoning because you can follow it yourself, and then judge any clinic, product, or claim, including mine, by the same standard.

Read in any order you like. Start wherever your own questions are loudest, and explore the guides below.

Ozempic and Wegovy are brands of Novo Nordisk; Mounjaro and Zepbound are brands of Eli Lilly; we are not affiliated. Compounded semaglutide and tirzepatide are not FDA-approved and are not identical to the brand drugs, and results vary.

Guides in this series

Frequently asked questions

What does weight loss evidence and science actually mean?

It means the body of careful research, and the standards for judging it, that tell us what genuinely helps people lose weight and keep it off. Strong evidence is tested more than once, reviewed by independent experts, stated with honest limits and disclosed conflicts, and consistent across several studies pointing the same direction. A single dramatic study is a starting question, not an answer.

Why should I be cautious about one impressive weight-loss study?

Because any single study is a snapshot of specific people, under specific conditions, for a specific length of time. It can be true and still not apply to you, and early results are sometimes softened or overturned by later work. Studies also report averages, and averages hide a wide range of individual outcomes, so a headline that turns an average into a promise has dropped the caution that made the study worth trusting.

If the trials look good, why do people still regain weight?

Because after weight loss the body pushes back: hunger rises and hormones shift in ways that favor regaining the weight. This is physiology, not a failure of willpower, and it is well documented across years of research. It means weight maintenance is its own distinct phase of care that needs ongoing support, and any plan treating it as automatic has skipped the hardest part.

How can I tell a considered treatment plan from an improvised one?

Look for a plan that follows recognized clinical guidelines and the standard of care, that is stated with honest confidence in some places and honest uncertainty in others, and that includes follow-up and a maintenance strategy rather than a one-time promise. A clinician who is certain about everything, or who guarantees a specific number on the scale, has usually stopped reading the evidence.

Are compounded semaglutide and tirzepatide backed by the same evidence as the brand drugs?

No. The pivotal trials studied the brand medications, and compounded semaglutide and tirzepatide are not FDA-approved and are not identical to the brand drugs, so results vary. Ozempic and Wegovy are brands of Novo Nordisk, and Mounjaro and Zepbound are brands of Eli Lilly; we are not affiliated. That distinction is exactly the kind of detail this hub teaches you to read carefully before making a decision.

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.